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Infection with HTLV-1 is associated with bronchiectasis
in Indigenous Australians. Previous studies have not
determined HTLV-1 proviral loads (pvl), which predict
risk of other HTLV-1 associated inflammatory diseases,
such as HTLV-1 associated myelopathy. Thirty-six Indi-
genous adults admitted to Alice Springs Hospital, June
2008 to December 2009, with radiologically confirmed
bronchiectasis, but no other HTLV-1 related disease,
were prospectively recruited and matched by age and
sex to 36 controls of the same ethno-geographic origin.
Case notes were reviewed from date of birth or first
admission to date of recruitment. HTLV-1 subtype C
pvl were determined at the Pasteur Institute, Paris.
HTLV-1 infection was more common among cases (25/
36; 69.4%) than their controls (15/36; 41.7%)(p<0.018).
Two cases were admitted in childhood with probable
infective dermatitis and two with recurrent strongyloi-
diasis unresponsive to treatment with thiabendazole. In
adulthood, cases (25/36; 69%) were more likely than
controls (5/25; 20%) to have positive or borderline
strongyloides serology (p<0.001). The mean HTLV-1 pvl
(±SEM) was significantly higher for cases (0.83±0.21%
PBMC) than controls (0.12±0.05% PBMC)(p=0.016) and
was nearly17 fold-higher compared to controls in which
bronchiectasis was excluded by HRCT (0.05±0.02%
PBMC; p=0.006). Twelve cases (33.3%) and 5 controls
(13.9%) died during 3 years of follow-up (p<0.052).
Cases died at a younger age (cases, 49±15; controls,
60±13)(p=0.15). In both groups HTLV-1 infected
patients were more likely to die: cases, 11/12 (92%); con-
trols, 4/5 (80%). HTLV-1-associated bronchiectasis is
associated with higher HTLV-1 pvl suggesting that this
condition results from an HTLV-1 driven inflammatory
process.
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